Human Factors Questions Drive Rise In FDA Inter-Center Consults
This article was originally published in The Gray Sheet
Executive Summary
Formal consultations between FDA's product centers are becoming more frequent, and they are often triggered by questions about human factors issues, says Office of Combination Products Director Thinh Nguyen.
You may also be interested in...
Reducing Waste In Combo Product Reviews: FDA Goes Lean
The agency disclosed plans to leverage "lean" management techniques, frequently employed in the private sector and by health care organizations, to streamline the process for reviewing new combination products.
Reducing Waste In Combo Product Reviews: FDA Goes Lean
The agency disclosed plans to leverage "lean" management techniques, frequently employed in the private sector and by health care organizations, to streamline the process for reviewing new combination products.
Podcast + Q&A: Combo Product Human Factors Guidance Follows Multi-Year Coalition Effort
Combination Products Coalition's Bradley Thompson discusses how the organization lobbied for changes to FDA's review process to bring more consistency in human factors requirements for combination products, resulting in a recent draft guidance document. Listen to the "Gray Sheet" podcast interview and read the Q&A.